OncoTherapy Science, Inc.

¥16.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4564Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (24.05%)
Div yield —
ROE (50.12%)
Biotechnology
Beta (5Y) 0.32
PE TTM —
TSR TTM (33.33%)
Mkt cap ¥6.532B
ROIC (30.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
2.20%
(80.78%)
Hold 2|2|11|7|5
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
0.41
0.39
0.38
0.43
24.04%
17.47%
2.81%
6.17%
Revenue¥M
668.8
669.1
707.4
705.5
12.19%
7.36%
9.83%
11.74%
Peers (US$41.47M)
Cap (US$)
PE
43.88M
—
Capital
TTM
5Y
10Y
Leveragex
1.186
0.173
0.176
EBIT/Intx
0.695
5.723
3.910
Own earn%
(271.82)
8.39
2.22
Sh yield%
37.97
24.05
22.71
Owners
Insiders/Inst%
6.33
36.12
Short interest%
4.64
SBC / revenue%
3.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
1–7
$1 testx
—
Incr. ROIC%
17